[1]
2019. Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis. Iranian Journal of Kidney Diseases. 13, 5 (Oct. 2019), 346–346.